MGP
WST icon

Metis Global Partners’s West Pharmaceutical WST Stock Holding History

Metis Global Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
3,360
-1,506
-31% -$460K 0.03% 405
2026
Q1 		$1.22M Sell
4,866
-1,839
-27% -$458K 0.03% 403
2025
Q4 		$1.84M Sell
6,705
-285
-4% -$78K 0.04% 334
2025
Q3 		$1.83M Sell
6,990
-430
-6% -$105K 0.04% 344
2025
Q2 		$1.62M Sell
7,420
-389
-5% -$83.2K 0.04% 355
2025
Q1 		$1.75M Buy
7,809
+1,379
+21% +$380K 0.05% 337
2024
Q4 		$2.11M Buy
6,430
+211
+3% +$66.4K 0.06% 267
2024
Q3 		$1.87M Buy
6,219
+500
+9% +$153K 0.06% 301
2024
Q2 		$1.88M Buy
5,719
+219
+4% +$77.4K 0.06% 261
2024
Q1 		$2.18M Buy
5,500
+66
+1% +$24.4K 0.08% 224
2023
Q4 		$1.91M Buy
5,434
+138
+3% +$48.8K 0.08% 250
2023
Q3 		$1.99M Buy
5,296
+425
+9% +$164K 0.1% 217
2023
Q2 		$1.86M Buy
4,871
+571
+13% +$204K 0.1% 211
2023
Q1 		$1.49M Sell
4,300
-72
-2% -$21K 0.1% 226
2022
Q4 		$1.03M Buy
4,372
+2,144
+96% +$508K 0.09% 249
2022
Q3 		$549K Buy
2,228
+529
+31% +$161K 0.09% 269
2022
Q2 		$513K Buy
1,699
+526
+45% +$171K 0.08% 284
2022
Q1 		$482K Buy
1,173
+527
+82% +$206K 0.06% 308
2021
Q4 		$303K Buy
+646
New +$278K 0.08% 272

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Metis Global Partners's WST Position: Q2 2026 in Review

Metis Global Partners reduced its West Pharmaceutical (WST) stake by 31% in Q2 2026, selling an estimated $460K and leaving 3,360 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #405.

Metis Global Partners first reported a position in WST in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.18M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Metis Global Partners held 3,360 shares of West Pharmaceutical worth $1.21M as of Q2 2026.
  • Metis Global Partners sold 1,506 West Pharmaceutical shares in Q2 2026, an estimated $460K.
  • West Pharmaceutical made up 0.03% of Metis Global Partners's portfolio in Q2 2026, its #405 holding.
  • Metis Global Partners first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's West Pharmaceutical position peaked at $2.18M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.